Dan Jackson

Current Contract

Contract Value Index (CVI)

Dan Jackson's $1.08M deal lands at a B- Contract Value Index, signaling a measured outcome for Detroit. The grade reflects the inherent tension in valuing a seventh-round rookie safety on a four-year rookie scale contract who has yet to prove durability at the professional level—his 2025 season produced 6 tackles across 1 game before a leg injury landed him on injured reserve, leaving no meaningful production foundation to justify premium capital allocation. At a safety position where even solid starters command multi-million AAV in free agency, Jackson's cost is rock-bottom and defensible, but that value proposition only holds if he can survive his second offseason healthy and earn snaps in 2026. The Lions' recent signings across the secondary and skill positions suggest the organization is moving forward with proven commodities rather than waiting on his recovery timeline, a clear organizational signal that patience for his development has real limits. His placement on the OTA medical watchlist heading into Year Two confirms that durability concerns have followed him into the offseason—a massive red flag for a player who has logged exactly one game and zero statistical foundation. The B- reflects what the contract itself is worth on paper: cheap capital with four years of control, but only viable if Jackson can stay healthy and eventually justify his roster spot through performance, a hurdle he has yet to clear.

Contracts in the Same Value Band

Other same-position deals the Contract Value Index also places in the B band — a quick read on where Dan's contract sits relative to comparable money.

Performance Analysis

Dan Jackson's on-field production earns a C+ performance grade against safety peers across the league. His 2025 season was defined by extreme scarcity: he appeared in just one game and logged six tackles before a leg injury landed him on injured reserve, leaving him with virtually no professional foundation to evaluate at the safety position. The limited tackle volume he did accumulate represents his only quantifiable strength from a rookie season cut short, but a single-game sample size offers no meaningful evidence of NFL-level consistency or coverage instincts. The durability concern is the elephant in the room — an injury that wiped out his entire first year, compounded by his presence on Detroit's OTA medical watchlist heading into 2026, signals that the Lions have legitimate questions about whether Jackson can stay healthy enough to hold a roster spot. For a seventh-round pick (230th overall) with no statistical track record and a contract worth $1.1M, the path forward runs entirely through a clean bill of health and a standout training camp; without it, the team's recent defensive signings — including Chuck Clark and other veteran safeties — suggest the organization is not banking on Jackson's immediate availability or upside. At 25 and in his second professional year, Jackson remains a high-variance developmental story whose entire 2026 trajectory depends on proving he can stay on the field and finally produce the kind of snap count volume needed to evaluate his actual capability as a safety.

How Dan Compares at the Position

Dan Jackson ranks 76th of 196 graded safeties by performance. That slots Dan between Ji'ayir Brown (C+) just ahead and Malaki Starks (C+) just behind.

Current Sentiment

Public perception of Dan Jackson sits at a F sentiment grade, capturing how the Detroit Lions fan base and beat writers are framing his role. The narrative around this seventh-round pick has been entirely defined by injury rather than promise—his placement on injured reserve before logging a single regular-season snap in 2025 created a media vacuum that a low-profile rookie simply cannot overcome, and the repetitive injury-only headline cycle has left nothing resembling credibility with fans or beat reporters. On the field, his rookie production mirrors the sentiment collapse: 6 tackles across 1 game before the leg injury shut him down, a performance grade of C+ that reflects the harsh reality that he hasn't played enough to warrant any evaluative coverage beyond "unknown quantity." The Lions' recent defensive back additions—Chuck Clark, Avonte Maddox, and others through the spring—signal organizational investment in proven names rather than patience for Jackson's recovery timeline, and the absence of any public coaching staff commentary on his health status only deepens the perception pressure heading into 2026. Jackson's path to relevance runs entirely through a clean bill of health and a standout training camp performance; without both, he remains a cautionary tale about durability at a critical position, not a prospect generating momentum.